Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01330004 · ClinicalTrials.gov registry record
Blood Pressure Change and Outcome
A clinical trial, sponsored by Renal Research Institute.
- Completed
- Registry status
- 12,695
- Enrollment target
NCT01330004: Completed study, sponsored by Renal Research Institute.
NCT01330004 is a clinical trial that has completed, run by Renal Research Institute. The registered enrollment target is 12,695 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01330004 has completed, sponsored by Renal Research Institute.
- COMPLETED
- Registry status
- 12,695 participants
- Enrollment target
Study Summary
Hyper- and hypotension are important predictors of survival in non-ESRD (end stage renal disease) population. In dialysis patients, however, it has been shown that higher blood pressure levels may actually be beneficial to patient outcomes. Dynamics of blood pressure evolution over time has not been previously studied in dialysis population. The investigators aim to understand how both blood pressure levels and blood pressure changes over time predict patient survival.
Primary Outcome
The ranges of blood pressure measurements in mmHg over time and the relation to patient outcomes (including survival)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12,695 participants |
| Start Date | 1999-01 |
| Est. Completion | 2010-12 |
What the finished NCT01330004 record still lists
NCT01330004 is an observational study that tracks outcomes without assigning an intervention. Its 12,695 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 0 interventions.
NCT01330004 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01330004 about?
NCT01330004 is a clinical study titled "Blood Pressure Change and Outcome". Hyper- and hypotension are important predictors of survival in non-ESRD (end stage renal disease) population. In dialysis patients, however, it has been shown that higher blood pressure levels may actually be beneficial to patient outcomes. Dynamics of blood pressure evolution over time has not been...
What is the current status of trial NCT01330004?
This trial is currently completed. The enrollment target is 12,695 participants. The study started on 1999-01. Estimated completion is 2010-12.
Who is sponsoring clinical trial NCT01330004?
This trial is sponsored by Renal Research Institute, which has 14 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT07037433 · 12,800 participants · Phase 3
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
- NCT03586895 · 12,838 participants · NA
e-Connect: A Service System Intervention for Justice Youth at Risk for Suicide
- NCT04888832 · 12,500 participants · NA
The Effect of Work Requirements in SNAP in Virginia
- NCT05452941 · 12,500 participants
A Study to Learn About How 20-Valent Pneumococcal Conjugate Vaccine Works in a Real-world Setting
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia